StratDeck

Two stocks in Healthcare

AbbVie vs Intuitive Surgical: profit, growth, debt and price compared

AbbVie and Intuitive Surgical are each stronger on 2 of 5 figures: AbbVie on price for its expected profit and price trend; Intuitive Surgical on profit margin and sales growth.

Figures as of 18 November 2026SEC EDGARYahoo Finance
Explore AbbVie's storyWhere next ↓

Save both stocks to your watchlist and revisit their latest fundamentals.

AbbVie and Intuitive Surgical side by side
AbbVieABBVIntuitive SurgicalISRG
Net margin15.7%Stronger: 25.5%
Revenue growth, past year+10.32%Stronger: +21.70%
Debt to equity——
Forward P/EStronger: 17.6×33.8×
Dividend yield2.42%—
AnalystsBuy · 26Buy · 30
From its 200-day averageStronger: +15.5%−2.6%

Share price over the past year

  • AbbVie+22.3%
  • Intuitive Surgical−23.0%

18 Nov 202518 Nov 2026

AbbVie or Intuitive Surgical: which is stronger?

  • ISRG

    Which is more profitable?

    Intuitive Surgical keeps more of each sale as profit: 25.5% against 15.7%.

  • ISRG

    Which is growing its sales faster?

    Intuitive Surgical is growing its sales faster: +21.70% over the past year, against +10.32%.

  • ABBV

    Which costs less for the profit it is expected to make?

    AbbVie costs less for the profit it is expected to make: 17.6× its forward earnings, against 33.8×.

  • Which pays more in dividends?

    AbbVie pays 2.42% a year in dividends for what a share costs, where Intuitive Surgical pays none.

  • Which do analysts rate higher?

    Analysts rate both the same: Buy.

  • ABBV

    Which is in the stronger price trend?

    AbbVie's price is in the stronger trend: 15.5% above its 200-day average, against 2.6% below.

What each company does

ABBVAbbVie

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.

Reports results on 3 February 2027

ISRGIntuitive Surgical

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally.

Reports results on 21 January 2027

This comparison is just the starting point.

Discover opportunities, understand companies and compare investments in one place. See how StratDeck works

Keep researching

Where next

Every US healthcare comparison

Free email

Up to speed in minutes, four times a week

Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.

Early access

Become a StratDeck founding user

Use StratDeck, tell us what's missing, and help decide what we build next.

100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.